SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-032584
Filing Date
2024-04-12
Accepted
2024-04-12 16:30:25
Documents
14
Period of Report
2024-04-10
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0203761-8k_aditxt.htm   iXBRL 8-K 25610
2 UNSECURED PROMISSORY NOTE DATED APRIL 10, 2024 ea020376101ex10-1_aditxtinc.htm EX-10.1 15354
  Complete submission text file 0001213900-24-032584.txt   220040

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE adtx-20240410.xsd EX-101.SCH 3009
4 XBRL LABEL FILE adtx-20240410_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE adtx-20240410_pre.xml EX-101.PRE 22355
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0203761-8k_aditxt_htm.xml XML 3705
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39336 | Film No.: 24841879
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)